Gelatin microspheres containing epirubicin: Pharmaceutical, pharmacokinetic and antitumour effect characterization

S.T.P. Pharma Sciences

Volumn 12, Issue 5, 2002, Pages 275-282

  Achim, M ^a   Risca, R ^a   Daicoviciu, D ^a   Leucuta, S E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Antitumour effect; Drug release; Epirubicin; Gelatin microspheres; Immunomodulator effect; Pharmacokinetics

Indexed keywords

EPIRUBICIN; MICROSPHERE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BOLUS INJECTION; CARDIOTOXICITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; EHRLICH ASCITES TUMOR; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; PHYSICAL CHEMISTRY; RAT; RISK MANAGEMENT;

EID: 0036749653     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Willmott N., Magee G.A., Cummings J., Halbert G.W., Smyth J. F. - Doxorubicin-loaded casein microspheres: protean nature of drug incorporation. - J. Pharm. Pharmacol., 44, 472-475, 1992.
2. Cummings J., Willmott N., Marley E., Smyth J. - Covalent coupling of doxorubicin in protein microspheres is a major determination of tumour drug disposition. - Biochemical Pharmacology, 41, 1849-1854, 1991.
3. Jones C., Burton M.A., Gray B.N. - Albumin microspheres as vehicles for the sustained and controled relase of doxorubicin. - J. Pharm. Pharmacol., 41, 813-816, 1989.
4. Changhong Yan, Xiongwei Li et al. - Anticancer gelatin microspheres with multiple functions. - Biomaterials, 12, 60-644, 1991.
5. Leucuta. S.E., Risca R., Daicoviciu D., Porutu D. - Albumin microspheres as a drug delivery system foe epirubicin: pharmaceutical, pharmacokinetic and biological aspects. - Int. J. Pharm., 41, 213-217, 1988.
6. Vandelli M.A., Rivasi F., Guerra P., Forni F., Arletti R. - Gelatin microspheres cross-linked with D,L glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. - Int. J. Pharm., 215, 175-184, 2001.
7. Bulgarelli E., Forni F. And Bernabei M.T. - Casein/ gelatin beads. I. Cross-linker solution compositin effect on cross-linking degree. - Int. J. Pharm., 190, 175-182, 1999.
8. Tomlinson E. - Microsphere delivery systems for drug targeting and controlled release. - Int. J. Pharm. Technol. Prod. Manuf., 4, 49, 1983.
9. Couvreur P., Roblot-Treupel L., Poupon M.F., Brasseur F., Puisieux F. - Nanoparticles as microcarriers for anticancer drugs. - Adv. Drug Deliv., 5, 209-230, 1990.
10. Leucuta S.E. - Micro and nanoparticles as drug carriers. - In: Nuclear Biological Chemical Risks, Current Capabilities and Perspectives for Protection, T.Sohns, V.A.Voicu (Eds.), NATO Science Series, Vol. 25, Kluwer Academic Publishers, 1999, pp. 411-439.
11. Okada H., Toguchi H. - Biodegradable microspheres in drug delivery. - Crit. Rev. Ther. Drug Carr. Syst., 12, 1-99, 1995.
12. Fujiwara K., Hayakawa K., Nagata Y., Hiraoka M., Nakamura T., Shimizu Y., Ikada Y. - Experimental embolization of rabbit renal arteries to compare the effects of poly L-lactic acid microspheres with and without epirubicin release against intra-arterial injection of epirubicin. - Cardiovascular and Interventional Radiology, 23, 218-223, 2000.
13. Welz M.M., Ofner C.M. - Examination of self-cross-linked gelatin as a hydrogel for controlled release. - J. Pharm. Sci., 81, 85-89, 1992.
14. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H. - Measurement of protein using bicinchoninic acid. - Analytical Biochemistry, 150, 76-85, 1985.
15. Lane B.C., Kan-Mitchell J., Mitchel M.S., Cooper S.M. - Structural evidence for distinct IgG subclass-specific Fc receptors mouse peritoneal macrophages. - J. Exp. Med., 152, 1147-1161, 1980.
16. Market M., Frei J. - The nergy metabolism of the leucocyte. X. Kinetics of oxygen consumption during phagocytosis by polymorphouclear leucocytes. - Enzyme, 23, 1255-1261, 1979
17. Rolland A. - Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound antracycline. - Int. J. Pharm., 54, 113-121, 1989.
18. Hakata T., Sato H., Watanabe Y., Matsumoto M. - Effect of formaldehyde on the physicochemical properties of soft gelatin calsule shells. - Chem. Pharm. Bull., 42, 1138-1142, 1994.
19. Vandelli M.A., Forni F., Ianuccelli V., Cameroni R. - The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres. - J. Pharm. Belg., 46, 381-388, 1991.
20. Vandeli M.A., Forni F., Coppi G., Cameroni R. - The effect of cross-linking time period upon the drug release and the dynamic swelling of gelatin microspheres. - Pharmazie, 46, 866-869, 1991.
21. Haiyun F., Alekha K.D. - Effect of cross-linkig on the in vitro release kinetics of doxorubicin from gelatin implants. - Int. J. Pharm., 213, 103-116, 2001.
22. Leo E., Vandelli M.A., Cameroni R., Forni F. - Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involment of the drug in the cross-linking process. - Int. J. Pharm., 155, 75-82, 1997.
23. Willmott N., Cummings J., Stuart J.F., Florence A.T. - Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat. - Biopharm. Drug Dispos., 6, 91-104, 1985.
24. Miyazaki S., Hashiguchi N., Yokouchi C., Takada M., Hou W.M. - Antitumour effect of fibrinogen microspheres containing doxorubicin on Ehrlich ascites carcinoma. - J. Pharm. Pharmacol., 38, 618-620, 1986.
25. Mayhew E., Rustum Y., Vail W.J. - Inhibition of liver metastases of M5076 tumor by liposome-entrapped adriamycin. - Cancer Drug Deliv., 1, 43-58, 1983.
26. Spreafico F., Vecchi A. et al. - Cancer chemotherapeutics as immunomodulators. - Springer Semin. Immunopathol., 8, 361-374, 1985.